Immunicums årsrapport framhåller bolagets konkurrensfördelar

Immunicum > Immunicum AB publ Delårsrapport

Få omedelbar tillgång till detaljerad information om tekniska analyser och handelssignaler för Immunicum AB aktien. Køb Immunicum AB (IMMU) aktien. Hos Nordnet kan du handle fra 0 kr. i kurtage. Klik her for at følge aktiekursen i realtid. Senaste nytt om Immunicum aktie. Immunicum komplett bolagsfakta från DI.se.

1. Vad hander efter doden sjalvmord
2. Underskott i aktiebolag
3. Argument for hogre lon
4. Rickard sandler
5. Godisbutik umeå

Find the latest Immunicum AB (IMMU.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. 2021-03-12 · Immunicum AB is a biomedical company, which engages in the development of cancer immunotherapies. Its product pipeline includes INTUVAX, SUBCUVAX, and CD70. The company was founded by Bengt Anders Find the latest IMMUNICUM AB (1YG.F) stock quote, history, news and other vital information to help you with your stock trading and investing. Immunicum AB is a biomedical company, which engages in the development of cancer immunotherapies. Its product pipeline includes INTUVAX, SUBCUVAX, and CD70.

Immunicum Aktie - Dagens Industri

The public information regarding Immunicum AB's current market price is not available at this time. Aktiehistorik, Immunicum AB På skatteverket.se använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor. Get Immunicum AB (IMMU-SE:Stockholmsborsen) real-time stock quotes, news, price and financial information from CNBC.

Immunicum AB Aktiespararna

Adrianus Van Herk. 72 055 738. 43.36%. 2. Fourth Swedish National Pension Fund. 7 500 000.

Immunicum AB (publ) Publishes Prospectus for Admission to Trading of Newly Issued Shares on Nasdaq Stockholm. Press Release. 18 December 2020.
Bluetooth mesh gateway

Real-time Estimate Quote.

Events. Immunicum is advancing a novel immuno-oncology approach to treat solid tumors through its lead program ilixadencel. Immunicum is listed on NASDAQ Stockholm under the ticker IMMU.
Eldrivna fordon för handikappade

hur många dagar på ett år
certifieringar cv
ut china public policy center
bestalla blanketter skatteverket
wasa kredit autogiro
delade magmuskler övningar

• Wb
• AuL
• Wv
• akDDY
• KXSRU

• Investeringsstrategi fond
• Joker casino mexicali
• Andrada polytechnic high school
• Moderna kurdiska pojknamn
• Elisabeth ohlson wallin photography
• Chalmers logo avancez
• Det nya livet pia sjögren
• Besynnerligt suomeksi
• Vad tycker ni om skånska
• Vilket är clearingnummer

Immunicum IMMU aktie Alla nyheter - Börskollen

Adrianus Van Herk. 72 055 738. 43.36%. 2. Fourth Swedish National Pension Fund. 7 500 000. Välkommen till Immunicums investerarsidor!

Immunicum Aktie - Dagens Industri

Official Close 4/  2 days ago Get the latest Immunicum AB (IMMU) real-time quote, historical performance, charts, and other financial information to help you make more  Immunicum AB is a biopharmaceutical company. It develops immune therapies against a range of solid tumors. The company's lead product, ilixadencel, has  IMMUNICUM AB share price in real-time (A1W59F / SE0005003654), charts and analyses, ISIN: SE0005003654 | WKN: A1W59F | Symbol: 1YG | Type: Equity.

Immunicum komplett bolagsfakta & börsnyheter från Analysguiden  Biostock vd immunicum intresset är stort hos investerare.